BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

North America

AstraZeneca Commits $50 Billion to U.S. Expansion by 2030 in Biggest-Ever Global Investment

Investment will support AstraZeneca’s ambition to reach $80 billion revenue by 2030, with 50% generated in th...

July 22, 2025 | News

TCAI Becomes First in U.S. to Implant Leadless Cardiac Resynchronization Device

Electrophysiologists at the Texas Cardiac Arrhythmia Institute (TCAI) at St. David's Medical Center recently became the first in the nation to implant an F...

July 21, 2025 | News

FDA Pulls Emergency Brake on Sarepta's Gene Therapy Trials Amid Fatal Safety Crisis

The U.S. Food and Drug Administration announced it has placed Sarepta Therapeutics investigational gene therapy clinical trials for limb girdle muscular dy...

July 21, 2025 | Regulatory

Thermo Fisher to Acquire Sanofi’s Ridgefield Site, Expanding U.S. Steriles Manufacturing Capacity

Thermo Fisher to Acquire Sanofi’s Steriles Manufacturing Site in Ridgefield, New Jersey to Produce Critical Medicines for Sanofi Enables Additional ...

July 17, 2025 | News

Thermo Fisher Scientific Expands Rapid CGP Access with Oncomine™ Comprehensive Assay Plus on Genexus™ System

Thermo Fisher Scientific announced that the Oncomine™ Comprehensive Assay Plus* is now available on the Ion Torrent™ Genexus™ System* hel...

July 15, 2025 | News

FDA Publishes First-Ever Public Database of Complete Response Letters (2020–2024) – Now Available for Download

Download Approved CRLs – 2020 to 2024 (external link) U.S. Food and Drug Administration (FDA) has, for the first time, made pub...

July 14, 2025 | Regulatory

Elegen and Nutcracker Therapeutics Launch Cell-Free Platform Pilot to Transform RNA-Based Personalised Cancer Therapeutics

Elegen, a global leader in next-generation DNA manufacturing, and Nutcracker Therapeutics, a global leader in next-generation RNA design and manufactu...

July 14, 2025 | News

Merck & Co. (MSD Outside U.S. and Canada) to Acquire Verona Pharma for $10 Billion, Expanding Respiratory Portfolio with Ohtuvayre®

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, and Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma”), a biopharmaceu...

July 04, 2025 | News

Elevaris Medical Devices Accelerates Product Development with On-Site XLerator Live Prototyping Program

Elevaris Medical Devices, a Contract Development and Manufacturing Organization (CDMO) for industry-leading, multi-national healthcare companies, global me...

July 11, 2025 | News

I Peace and Vita Therapeutics Partner to Develop Universal Hypoimmune iPSC Lines for Cell Therapy

Leading GMP cell CDMO I Peace, Inc. specializing in induced pluripotent stem cells (iPSCs) and iPSC-derived cell therapies, announced that the co...

July 11, 2025 | News

Earendil Labs Completes First Cohort Dosing in Phase 1 Trial of Novel Anti-TL1A Antibody HXN-1001

Earendil Labs, an AI-empowered biotechnology company, announced that it has completed cohort 1 dosing in a phase 1 trial for a novel anti-TL1A antibo...

July 11, 2025 | News

Univercells Technologies and Repligen Collaborate to Advance Real-Time Monitoring in Viral Vector and Vaccine Manufacturing

Univercells Technologies, a Donaldson Life Sciences business and global provider of bioprocessing solutions, announced a collaboration with Repli...

July 10, 2025 | News

Quanterix Completes Acquisition of Akoya Biosciences, Expanding Leadership in Multi-Tissue Biomarker Detection

Quanterix Corporation, a company fueling scientific discovery through ultra-sensitive biomarker detection, announced that it has completed its previously a...

July 09, 2025 | News

Sirtex Secures FDA Approval for SIR-Spheres® Y-90 in Treating Unresectable Hepatocellular Carcinoma

Sirtex Medical ("Sirtex"), a leading manufacturer of interventional oncology solutions, today announced that the U.S. Food and Drug Administration (F...

July 08, 2025 | News

Stay Connected